John Lanza sold $16k of GSBD
See Remarks at Goldman Sachs BDC, Inc.. 1,250 shares at an average of $12.85, traded Nov 22, 2024, filed Nov 26, 2024.
Score components
- +15RoleOfficer
- 0Trade size$16k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -2.4%, 3m +4.2%, 6m -7.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000895345-24-000604, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 22, 2024 | SOpen-market sale Common Stock, par value $0.001 per share | -1,250 | $12.85 | $16k | 0 | Nov 26, 2024 |
Related signals
Other insiders at Goldman Sachs BDC, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | GSBDbuy Goldman Sachs BDC, Inc. | Timothy J Leach director | $18k 2,004 shares | +11% | |
| 52Moderate | GSBDbuy Goldman Sachs BDC, Inc. | Carlos E Evans director | $451k 50,000 shares | +346% | |
| 47Moderate | GSBDbuy Goldman Sachs BDC, Inc. | Tucker Greene See Remarks | $104k 10,500 shares | - | |
| 46Moderate | GSBDbuy Goldman Sachs BDC, Inc. | Vivek Bantwal Co-Chief Executive Officer | $250k 22,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.